Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 599

1.

Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, García-Carrasco M, Munguía-Realpozo P, Etchegaray-Morales I, Morales-Sánchez H, Berra-Romani R, Cervera R.

Atherosclerosis. 2020 Jan 31;297:55-63. doi: 10.1016/j.atherosclerosis.2020.01.028. [Epub ahead of print]

PMID:
32078830
2.

Precision medicine and the antiphospholipid syndrome: what is the future?

Rodriguez-Pintó I, Espinosa G, Cervera R.

Clin Rheumatol. 2020 Feb 15. doi: 10.1007/s10067-020-04987-8. [Epub ahead of print] No abstract available.

PMID:
32060811
3.

Treat-to-target in systemic lupus erythematosus: Where are we?

Ríos-Garcés R, Espinosa G, van Vollenhoven R, Cervera R.

Eur J Intern Med. 2020 Feb 1. pii: S0953-6205(20)30018-2. doi: 10.1016/j.ejim.2020.01.018. [Epub ahead of print] Review.

PMID:
32014364
4.

Plasma exchange in catastrophic antiphospholipid syndrome.

Rodríguez-Pintó I, Lozano M, Cid J, Espinosa G, Cervera R.

Presse Med. 2019 Nov;48(11 Pt 2):347-353. doi: 10.1016/j.lpm.2019.10.003. Epub 2019 Nov 4. Review.

PMID:
31694791
5.

Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms.

Moroni L, Restovic G, Cervera R, Espinosa G, Viñas O, García M, Sampietro-Colom L.

J Rheumatol. 2019 Nov 1. pii: jrheum.190533. doi: 10.3899/jrheum.190533. [Epub ahead of print]

PMID:
31676692
6.

Treatment for refractory lupus nephritis: Rituximab vs triple target therapy.

Cervera R, Mosca M, Ríos-Garcés R, Espinosa G, Trujillo H, Bada T, Praga M.

Autoimmun Rev. 2019 Dec;18(12):102406. doi: 10.1016/j.autrev.2019.102406. Epub 2019 Oct 22. Review. No abstract available.

PMID:
31654743
7.

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Hoxha A, Tincani A, Nalli C, Marozio L, Maina A, Espinosa G, Ríos-Garcés R, Cervera R, Carolis S, Monteleone G, Latino O, Udry S, LLurba E, Garrido-Gimenez C, Trespidi L, Gerosa M, Chighizola CB, Rovere-Querini P, Canti V, Mayer-Pickel K, Tabacco S, Arnau A, Trapé J, Ruiz-Hidalgo D, Sos L, Farran-Codina I.

Rheumatology (Oxford). 2019 Oct 3. pii: kez419. doi: 10.1093/rheumatology/kez419. [Epub ahead of print]

PMID:
31580459
8.

Associations among classification criteria items within systemic lupus erythematosus.

Touma Z, Cervera R, Brinks R, Lorenzoni V, Tani C, Hoyer BF, Costenbader KH, Sebastiani GD, Navarra SV, Bonfa E, Ramsey-Goldman R, Tedeschi SK, Dörner T, Johnson SR, Aringer M, Mosca M; ACR/EULAR group, New SLE classification criteria for clinical research are being developed, sponsored by EULAR, ACR.

Arthritis Care Res (Hoboken). 2019 Sep 27. doi: 10.1002/acr.24078. [Epub ahead of print]

PMID:
31560454
9.

Systemic lupus erythematosus and hypertension.

Munguia-Realpozo P, Mendoza-Pinto C, Sierra Benito C, Escarcega RO, Garcia-Carrasco M, Mendez Martinez S, Etchegaray Morales I, Galvez Romero JL, Ruiz-Arguelles A, Cervera R.

Autoimmun Rev. 2019 Oct;18(10):102371. doi: 10.1016/j.autrev.2019.102371. Epub 2019 Aug 12. Review.

PMID:
31415907
10.

Prevalence of Rheumatic Diseases and Quality of Life in the Saraguro Indigenous People, Ecuador: A Cross-sectional Community-Based Study.

Guevara SV, Feicán EA, Peláez I, Valdiviezo WA, Montaleza MA, Molina GM, Ortega NR, Delgado JA, Chimbo LE, Hernandez MV, Sanin LH, Cervera R.

J Clin Rheumatol. 2019 Aug 13. doi: 10.1097/RHU.0000000000001131. [Epub ahead of print]

PMID:
31415477
11.

Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.

Sanchez-Redondo J, Espinosa G, Varillas Delgado D, Cervera R.

Clin Ther. 2019 Sep;41(9):1839-1862. doi: 10.1016/j.clinthera.2019.06.015. Epub 2019 Aug 10. Review.

PMID:
31405527
12.

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.

Arthritis Rheumatol. 2019 Sep;71(9):1400-1412. doi: 10.1002/art.40930. Epub 2019 Aug 6.

PMID:
31385462
13.

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR.

Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5. Review.

14.

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.

Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H; APS ACTION.

J Thromb Haemost. 2019 Dec;17(12):2069-2080. doi: 10.1111/jth.14596. Epub 2019 Sep 8.

PMID:
31364274
15.

Causes and factors related to hospitalizations in patients with systemic lupus erythematosus: analysis of a 20-year period (1995-2015) from a single referral centre in Catalonia.

Rosa GPD, Ortega MF, Teixeira A, Espinosa G, Cervera R.

Lupus. 2019 Aug;28(9):1158-1166. doi: 10.1177/0961203319861685. Epub 2019 Jul 12.

PMID:
31299879
16.

Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting.

Anjo C, Mascaró JM Jr, Espinosa G, Cervera R.

Scand J Rheumatol. 2019 Nov;48(6):469-473. doi: 10.1080/03009742.2019.1603324. Epub 2019 Jul 2.

PMID:
31264525
17.

Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et al.

Gómez-Puerta JA, Cervera R, Alarcón GS.

Arthritis Rheumatol. 2019 Oct;71(10):1768-1769. doi: 10.1002/art.41002. Epub 2019 Sep 2. No abstract available.

PMID:
31131989
18.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM.

Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15.

PMID:
31092409
19.

Autoantibodies, elevated cytokines, and neurocognitive abnormalities in offspring of women with systemic lupus erythematosus: comparison with healthy controls.

Gariup M, Lera-Miguel S, Torres F, Varela E, Serra-Pagès C, González-Navarro A, Espinosa G, Lázaro L, Cervera R, Morer A.

Clin Rheumatol. 2019 Sep;38(9):2529-2539. doi: 10.1007/s10067-019-04495-4. Epub 2019 Apr 24.

PMID:
31020474
20.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
21.

[Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain].

Puig L, Ruiz de Morales JG, Dauden E, Andreu JL, Cervera R, Adán A, Marsal S, Escobar C, Hinojosa J, Palau J, Arraiza A, Casado P, Codesido M, Pascual C, Saldaña R, Gil Á.

Rev Esp Salud Publica. 2019 Mar 25;93. pii: e201903013. Spanish.

22.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J, Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I; EUROAPS Study Group.

Autoimmun Rev. 2019 Apr;18(4):406-414. doi: 10.1016/j.autrev.2018.12.006. Epub 2019 Feb 15.

PMID:
30772493
23.

Corrigendum to 'Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis'. [AUTREV 18-2 (2019) 184-191].

García-Carrasco M, Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, Vallejo-Ruiz V, Munguía-Realpozo P, Colombo AL, Cervera R.

Autoimmun Rev. 2019 Apr;18(4):437. doi: 10.1016/j.autrev.2019.02.001. Epub 2019 Feb 12. No abstract available.

PMID:
30770318
24.

Reply to the editor.

Garcia-Carrasco M, Mendoza-Pinto C, Rojas-Villarraga A, Molano-Gonzalez N, Vallejo-Ruiz V, Munguia-Realpozo P, Colombo AL, Cervera R.

Autoimmun Rev. 2019 Apr;18(4):435-436. doi: 10.1016/j.autrev.2019.02.007. Epub 2019 Feb 10. No abstract available.

PMID:
30743081
25.

Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis.

García-Carrasco M, Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, Vallejo-Ruiz V, Munguía-Realpozo P, Colombo AL, Cervera R.

Autoimmun Rev. 2019 Feb;18(2):184-191. doi: 10.1016/j.autrev.2018.09.001. Epub 2018 Dec 18. Erratum in: Autoimmun Rev. 2019 Apr;18(4):437.

PMID:
30572140
26.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

27.

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

Johnson SR, Khanna D, Daikh D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, Hiepe F, Sánchez-Guerrero J, Massarotti E, Boumpas DT, Costenbader KH, Jayne D, Dörner T, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Aringer M.

J Rheumatol. 2019 Jul;46(7):721-726. doi: 10.3899/jrheum.180478. Epub 2018 Dec 15.

PMID:
30554156
28.

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.

Mertz P, Belot A, Cervera R, Chuah TY, Dagna L, Damian L, Danda D, D'cruz D, Espinosa G, Frances C, Jayne D, Ooi KK, Kucharz EJ, Lebovics R, Marie I, Moulis G, Peng S, Sharma A, Suzuki N, Tanaka T, Van Vollenhoven R, Sibilia J, Gottenberg JE, Chasset F, Arnaud L.

Joint Bone Spine. 2019 May;86(3):363-368. doi: 10.1016/j.jbspin.2018.11.001. Epub 2018 Nov 15.

PMID:
30448476
29.

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5. Review.

PMID:
30408582
30.

Antiphospholipid syndrome: state of the art on clinical practice guidelines.

Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A.

RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. eCollection 2018.

31.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
32.

The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome.

García-Carrasco M, Jiménez-Herrera EA, Gálvez-Romero JL, Mendoza-Pinto C, Méndez-Martínez S, Etchegaray-Morales I, Munguía-Realpozo P, Vázquez de Lara-Cisneros L, Santa Cruz FJ, Cervera R.

Lupus. 2018 Dec;27(14):2181-2189. doi: 10.1177/0961203318801520. Epub 2018 Oct 3. Review.

PMID:
30282560
33.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2019 Apr;126(5):656-661. doi: 10.1111/1471-0528.15469. Epub 2018 Oct 24.

PMID:
30222236
34.

Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant).

Mendoza-Pinto C, García-Carrasco M, Cervera R.

Curr Rheumatol Rep. 2018 Aug 20;20(10):62. doi: 10.1007/s11926-018-0773-x. Review.

PMID:
30123926
35.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 2.

PMID:
30079582
36.

The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome.

Plasín-Rodríguez MA, Rodríguez-Pintó I, Patricio P, Monteagudo J, Cervera R, Reverter JC, Espinosa G, Tàssies D.

Thromb Res. 2018 Sep;169:128-134. doi: 10.1016/j.thromres.2018.07.006. Epub 2018 Jul 4.

PMID:
30048851
37.

McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.

Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A.

J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14192. [Epub ahead of print]

PMID:
29978552
38.

Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.

Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, Jiménez-Herrera EA, León-Vázquez ML, Montiel-Jarquín Á, García-Carrasco M, Cervera R.

PLoS One. 2018 Jun 13;13(6):e0196113. doi: 10.1371/journal.pone.0196113. eCollection 2018. Review.

39.

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review.

Cervera R, Rodríguez-Pintó I, Espinosa G.

J Autoimmun. 2018 Aug;92:1-11. doi: 10.1016/j.jaut.2018.05.007. Epub 2018 May 18. Review.

PMID:
29779928
40.

Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases.

Escárcega RO, Lipinski MJ, García-Carrasco M, Mendoza-Pinto C, Galvez-Romero JL, Cervera R.

Autoimmun Rev. 2018 Jul;17(7):703-708. doi: 10.1016/j.autrev.2018.01.021. Epub 2018 May 3. Review.

PMID:
29730525
41.

Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.

Quintana R, Goñi M, Mathern N, Jorfen M, Conti S, Nieto R, Sanabria A, Prigione C, Silvestre AMR, García V, Pons-Estel G, Cervera R, García C, Peláez-Ballestas I, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2018 Sep;37(9):2323-2330. doi: 10.1007/s10067-018-4103-5. Epub 2018 Apr 19.

PMID:
29675622
42.

The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients.

Rodríguez-Pintó I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R; CAPS Registry Project Group .

Rheumatology (Oxford). 2018 Jul 1;57(7):1264-1270. doi: 10.1093/rheumatology/key082.

PMID:
29660074
43.

Future Perspectives in the Diagnosis of Neuropsychiatric Lupus by Advanced Magnetic Resonance Imaging Techniques.

Sarbu N, Sarbu MI, Bargallo N, Cervera R.

Curr Rheumatol Rev. 2018;14(3):213-218. doi: 10.2174/1573397114666180411093655. Review.

PMID:
29637864
44.

Association between allelic variants of the human glucocorticoid receptor gene and autoimmune diseases: A systematic review and meta-analysis.

Herrera C, Marcos M, Carbonell C, Mirón-Canelo JA, Espinosa G, Cervera R, Chamorro AJ.

Autoimmun Rev. 2018 May;17(5):449-456. doi: 10.1016/j.autrev.2017.11.034. Epub 2018 Mar 8. Review.

PMID:
29526633
45.

Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Barturen G, Beretta L, Cervera R, Van Vollenhoven R, Alarcón-Riquelme ME.

Nat Rev Rheumatol. 2018 Feb 21;14(3):180. doi: 10.1038/nrrheum.2018.23.

PMID:
29463931
46.

Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Barturen G, Beretta L, Cervera R, Van Vollenhoven R, Alarcón-Riquelme ME.

Nat Rev Rheumatol. 2018 Jan 24;14(2):75-93. doi: 10.1038/nrrheum.2017.220. Review. Erratum in: Nat Rev Rheumatol. 2018 Feb 21;14 (3):180.

PMID:
29362467
47.

Systemic lupus erythematosus.

Furie R, Cervera R.

Best Pract Res Clin Rheumatol. 2017 Jun;31(3):289-290. doi: 10.1016/j.berh.2017.10.005. Epub 2017 Nov 2. No abstract available.

PMID:
29224671
48.

Detection limit of Mycobacterium chimaera in water samples for monitoring medical device safety: insights from a pilot experimental series.

Schreiber PW, Köhler N, Cervera R, Hasse B, Sax H, Keller PM.

J Hosp Infect. 2018 Jul;99(3):284-289. doi: 10.1016/j.jhin.2017.11.007. Epub 2017 Nov 21.

49.

All that glitters is not lupus.

López-Mato P, Zamora-Martínez C, Carbajal S, Estevez M, Rodriguez-Pinto I, Cervera R, Prieto-González S, Espinosa G.

Lupus. 2017 Jan 1:961203317742713. doi: 10.1177/0961203317742713. [Epub ahead of print] No abstract available.

PMID:
29153011
50.

Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.

Gómez-Puerta JA, Ortiz-Reyes B, Urrego T, Vanegas-García AL, Muñoz CH, González LA, Cervera R, Vásquez G.

Lupus. 2018 Apr;27(4):637-646. doi: 10.1177/0961203317738226. Epub 2017 Oct 26.

PMID:
29073812

Supplemental Content

Loading ...
Support Center